看见一个 Expert Review of Anticancer Therapy。你们前面用依维莫斯,血、肝肾功能还好。下一步是否考虑索拉非尼+依维莫斯。供你参考。
6 w/ F$ e% k B! F) B) T. j) A# J% Y W
' F& W: Z& ~# o# X2 h+ W8 }
Currently available feasibility data for possible combination strategies.
9 \3 w0 }! B3 k5 g) [. u————————————————————————————————& z# Q. v! o+ Y
Combination Feasibility according to preliminary data % O4 A8 M% ^4 T: G: ?! D9 X$ O
——————————————————————————————————. e; Z+ J( J- `! U( A
Bevacizumab + sorafenib Yes, reduced dose
1 H2 i7 C. @7 r7 r3 }! `Bevacizumab + sunitinib† No W, `6 A3 i6 y- J) v
Bevacizumab + temsirolimus Yes 2 t* F: F; r; W" S( M
Bevacizumab + everolimus Yes
3 X6 O$ @1 g" H& |! hSorafenib + sunitinib ?
+ C+ A' F! t8 G) A6 OSorafenib + temsirolimus Yes, reduced dose ) e0 c' f' m7 r. p k
Sorafenib + everolimus Yes, reduced dose
9 V, ~( X: u; n) |. sSunitinib + temsirolimus† No 1 F" z/ | Q; [* v+ f
Sunitinib + everolimus ? ( u3 l9 e. i V2 @0 A }7 H( C
Temsirolimus + everolimus ? & S( N$ H; K$ ^# {6 |4 l2 i
————————————————————
. n N1 Y n; ]9 M0 J( U0 h†Led to US FDA warning.) p/ e) Z. B4 C; A. l0 k
?: As yet unattempted combination.
( ^3 M. R( ?' k |